REQUEST A DEMO
Total
USD $0.00
Search more companies

Apex Pharmachem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Apex Pharmachem Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Apex Pharmachem Private Limited is an unlisted company, incorporated on 17/04/2001. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ2001PTC039424 and registration number is 039424. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
193/1, 2Nd Phase, G.I.D.C,
Valsad; Gujarat; Postal Code: 396195

Contact Details: Purchase the Apex Pharmachem Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apex Pharmachem Private Limited report to view the information.
Registered Capital:
Purchase the Apex Pharmachem Private Limited report to view the information.
Financial Auditors:
Purchase the Apex Pharmachem Private Limited report to view the information.
Incorporation Date:
April 17, 2001
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Apex Pharmachem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-18.11%
Total operating revenue
-17.52%
Operating profit (EBIT)
22.72%
EBITDA
20.78%
Net Profit (Loss) for the Period
9.99%
Total assets
5.13%
Total equity
28.41%
Operating Profit Margin (ROS)
17.46%
Net Profit Margin
9.92%
Return on Equity (ROE)
-3.7%
Quick Ratio
5.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?